key: cord-0935325-v4pjygky
authors: Natale, Vazzana; Ognibene, Silvia; Dipaola, Francesco
title: “Acute” monoclonal gammopathy in severe COVID-19
date: 2020-06-09
journal: Hematol Transfus Cell Ther
DOI: 10.1016/j.htct.2020.05.002
sha: b9a714c2b6f6be2d7790240211fec0bab798710f
doc_id: 935325
cord_uid: v4pjygky

nan

Laboratory findings in severe coronavirus disease (COVID)-19 may include lymphopenia and elevated D-dimer, lactate dehydrogenase (LDH), C-reactive protein (CRP), and ferritin (1) . Several quantitative and functional abnormalities in lymphocyte populations have been reported in patients with SARS-CoV-2 infection, with evidence of depletion of cytotoxic T-lymphocytes and natural killer cells (2) . Lymphopenia has been identified as a prognostic marker for poor outcomes as it could be in correlation with cytokine storm (1). Though numerically depleted, circulating reactive lymphocytes were detectable in a consistent proportion of patients, some of them with a lymphoplasmacytic phenotype (3, 4) . Whether this cell population is related to polyclonal or monoclonal hypergammaglobulinemia is still unknown. A monoclonal band was found on SPEP and it was characterized as Ig-G lambda by immunofixation.

Steroid treatment was added, and non-invasive ventilation was necessary from D17 to D21, when initial improvement in his respiratory status was observed. A repeated SPEP showed a significant 

HCQ+LPV/r, hydroxychloroquine plus lopinavir/ritonavir, HCQ+DRV/c, hydroxychloroquine plus darunavir/cobicistat; VM, Venturi mask.

Hematological findings and complications of COVID-19

Functional exhaustion of antiviral lymphocytes in COVID-19 patients

Hematologic parameters in patients with COVID-19 infection

Plasmacytoid lymphocytes in SARS-CoV-2 infection (Covid-19)

HLH Across Speciality Collaboration, UK. COVID-19: consider cytokine storm syndromes and immunosuppression

IL-6 supports the generation of human long-lived plasma cells in combination with either APRIL or stromal cellsoluble factors